Abstract
Ocular surface disease (OSD) is a multifactorial condition of the ocular surface with a great impact on quality of life and epidemiological importance. The use of blood products and components has gained more space for their treatment. Autologous serum (AS) is now widely used with proven efficacy for treating ocular surface disease. Platelet-rich plasma (PRP) has also been shown to be eff…